Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  01/10/2008
 
Trade Name:  Alvesco Inhalation Aerosol, 80 mcg & 160 mcg
 
Generic or Proper Name (*):  ciclesonide
 
Indications Studied:  Treatment of asthma in patients 12 years of age and older.
 
Therapeutic Category:  Antiasthmatic
 
Ages Studied:  4-11 years
 
Study #:  1
 
Study Type:  Efficacy/Safety
 
Study Design:  Single-Blind/Placebo/Parallel Group/Dose Response
 
No Patients:  514
 
No Centers:  67
 
No Countries:  2
 
BPCA(B), PREA(P):  P
 
-
-